MaryRose Reaston

MaryRose Reaston

MaryRose Reaston is the co-founder, CEO and chief science officer of Emerge Diagnostics, which focuses on better outcomes for musculoskeletal disorders via early resolution and enhanced treatment options for soft-tissue injuries.

Emerge Diagnostics was created to commercialize the electrodiagnostic functional assessment (EFA).

Recent Articles by MaryRose Reaston

What An Employer Can Do To Reduce Soft Tissue Injuries In The Transportation Industry

The trucking industry accounted for nearly 20 percent of all days-away-from-work cases in 2011. Correspondingly, trucking was among the seven occupations which had an incidence rate greater than 300 cases per 10,000 full-time workers and who had greater than 20,000 days-away-from-work cases. OSHA defines a Musculoskeletal Disorder (MSD) as an injury of the muscles, nerves, […]

Connect With MaryRose Reaston

Connect with Dave Walker on LinkedIn Connect with Dave Walker on Facebook

  • Enterprise Risk Management
  • Healthcare
  • Innovation & Technology
  • Insurance Law
  • Workers Compensation
Do NOT follow this link or you will be banned from the site!